Five high-value biotech stocks to watch

Our new On the Radar report returns with fresh insights from Simos Simeonidis, PhD, Rodman & Renshaw's senior biotech analyst, who highlights biotech stocks which he believes will be good value plays in the months ahead. One reason Simeonidis is focusing on value, he explains, is that there are fewer catalyst-driven stories looming in his universe, "while I find myself speaking to investors more about value, especially given the uncertainty of the markets." In the mood for some market risk analysis? Then check out these five companies. Biotech stocks to watch >>